Literature DB >> 15278720

An 810 nm diode laser in the treatment of small (< or = 1.0 mm) leg veins: a preliminary assessment.

M A Trelles1, I Allones, O Trelles.   

Abstract

A consistently effective treatment for small leg veins (< or = 1.0 mm) is still being sought. The efficacy of an 810 nm diode laser in vein removal was assessed in a preliminary study. Fifteen females, skin types I to III, vein diameters 0.5-1 mm, aged from 25 to 42 years, participated in the study. An 810 nm diode laser (90 W, 20 ms/pulse, 10 Hz rep rate, 4.0 mm hand piece) was applied along the target veins. Biopsies were taken from two patients before and after the first treatment session. No compression was applied post-treatment. Four weeks later, a second treatment was given. Results were assessed subjectively from the patients' satisfaction index (SI) and objectively from clinical photography done by an independent clinician, who also judged the venous morphology before and 4 weeks after the second session. All patients completed the trial. Pain was moderate to severe at the time of treatment and erythema which was mild, which was seen in all 15 patients; oedema occurred in 12 patients and blistering in only one. No scarring was noticed. The overall satisfaction indices at the 4- and 8-week assessments were 20.7% and 55.1%, respectively. No patient got worse. The objective evaluations at the 4- and 8-week assessments showed increasing improvement in all aspects examined. Pain at the time of treatment was a problem for all patients, so epidermal cooling should be added. Despite this, the 810 laser diode was an interesting and promising device for treatment of small leg veins, warranting further study in larger patient cohorts with a longer-term follow up.

Entities:  

Mesh:

Year:  2004        PMID: 15278720     DOI: 10.1007/s10103-004-0295-9

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  9 in total

1.  The melanosome: threshold temperature for explosive vaporization and internal absorption coefficient during pulsed laser irradiation.

Authors:  S L Jacques; D J McAuliffe
Journal:  Photochem Photobiol       Date:  1991-06       Impact factor: 3.421

Review 2.  Basic laser principles.

Authors:  R M Herd; J S Dover; K A Arndt
Journal:  Dermatol Clin       Date:  1997-07       Impact factor: 3.478

3.  Laser assisted skin closure (LASC) by using a 815-nm diode-laser system accelerates and improves wound healing.

Authors:  A Capon; E Souil; B Gauthier; C Sumian; M Bachelet; B Buys; B S Polla; S Mordon
Journal:  Lasers Surg Med       Date:  2001       Impact factor: 4.025

4.  Vessel hyalinization phenomenon in the laser treatment of tuberous hemangiomas and port wine stains.

Authors:  M A Trelles; W Verkruysse; E Mayayo; M Velez; J W Pickering
Journal:  J Dermatol Sci       Date:  1995-01       Impact factor: 4.563

Review 5.  The role of lasers and light sources in the treatment of leg veins.

Authors:  J S Dover; N S Sadick; M P Goldman
Journal:  Dermatol Surg       Date:  1999-04       Impact factor: 3.398

6.  Laser therapy of telangiectatic leg veins: clinical evaluation of the 810 nm diode laser.

Authors:  S Varma; S W Lanigan
Journal:  Clin Exp Dermatol       Date:  2000-07       Impact factor: 3.470

7.  Possible mechanisms for an irregular vessel coagulation when long laser pulses are used in the treatment of port-wine stains.

Authors:  M A Trelles; L O Svaasand; M Vélez; K Trelles; R Fernández; W Verkruysse
Journal:  J Dermatol Sci       Date:  1996-11       Impact factor: 4.563

8.  Treatment of leg telangiectases with a 532 nm KTP laser in multipulse mode.

Authors:  N Fournier; D Brisot; S Mordon
Journal:  Dermatol Surg       Date:  2002-07       Impact factor: 3.398

9.  Using a "non uniform pulse sequence" can improve selective coagulation with a Nd:YAG laser (1.06 microm) thanks to Met-hemoglobin absorption: a clinical study on blue leg veins.

Authors:  Serge Mordon; Dominique Brisot; Nathalie Fournier
Journal:  Lasers Surg Med       Date:  2003       Impact factor: 4.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.